185 related articles for article (PubMed ID: 19653711)
1. Histopathologic risk factors in retinoblastoma in India.
Gupta R; Vemuganti GK; Reddy VA; Honavar SG
Arch Pathol Lab Med; 2009 Aug; 133(8):1210-4. PubMed ID: 19653711
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of high risk histopathology in retinoblastoma.
Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
[TBL] [Abstract][Full Text] [Related]
3. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study.
Kaliki S; Srinivasan V; Gupta A; Mishra DK; Naik MN
Ophthalmology; 2015 Jun; 122(6):1165-72. PubMed ID: 25841975
[TBL] [Abstract][Full Text] [Related]
4. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
Fabian ID; Stacey AW; Chowdhury T; Duncan C; Karaa EK; Scheimberg I; Reddy MA; Sagoo MS
Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
[TBL] [Abstract][Full Text] [Related]
5. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country.
Kashyap S; Sethi S; Meel R; Pushker N; Sen S; Bajaj MS; Chandra M; Ghose S
Arch Pathol Lab Med; 2012 Feb; 136(2):190-3. PubMed ID: 22288967
[TBL] [Abstract][Full Text] [Related]
6. Calcification in retinoblastoma: histopathologic findings and statistical analysis of 302 cases.
Levy J; Frenkel S; Baras M; Neufeld M; Pe'er J
Br J Ophthalmol; 2011 Aug; 95(8):1145-50. PubMed ID: 21273212
[TBL] [Abstract][Full Text] [Related]
7. Postenucleation adjuvant therapy in high-risk retinoblastoma.
Honavar SG; Singh AD; Shields CL; Meadows AT; Demirci H; Cater J; Shields JA
Arch Ophthalmol; 2002 Jul; 120(7):923-31. PubMed ID: 12096963
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of high-risk histopathologic features of 482 primarily enucleated retinoblastomas].
Xu XL; Li B; Gao F; Zhang ZB
Zhonghua Yan Ke Za Zhi; 2018 Oct; 54(10):782-786. PubMed ID: 30347567
[No Abstract] [Full Text] [Related]
9. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
[TBL] [Abstract][Full Text] [Related]
10. Defining High-risk Retinoblastoma: A Multicenter Global Survey.
Kaliki S; Shields CL; Cassoux N; Munier FL; Chantada G; Grossniklaus HE; Yoshikawa H; Fabian ID; Berry JL; McKenzie JD; Kimani K; Reddy MA; Parulekar M; Tanabe M; Furuta M; Grigorovski N; Chevez-Barrios P; Scanlan P; Eagle RC; Rashid R; Coronado RD; Sultana S; Staffieri S; Frenkel S; Suzuki S; Ushakova TL; Ji X
JAMA Ophthalmol; 2022 Jan; 140(1):30-36. PubMed ID: 34762098
[TBL] [Abstract][Full Text] [Related]
11. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study.
Eagle RC
Arch Pathol Lab Med; 2009 Aug; 133(8):1203-9. PubMed ID: 19653710
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
[TBL] [Abstract][Full Text] [Related]
13. [Retinoblastoma spontaneous regression: clinical and histopathologic analysis].
Xu X; Li B; Wang Y; Gao F; Zhang Z
Zhonghua Yan Ke Za Zhi; 2014 Oct; 50(10):729-32. PubMed ID: 25547573
[TBL] [Abstract][Full Text] [Related]
14. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
[TBL] [Abstract][Full Text] [Related]
15. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
[TBL] [Abstract][Full Text] [Related]
16. [Histopathologic findings in retinoblastoma].
de Souza Filho JP; Martins MC; Torres VL; Dias AB; Lowen MS; Pires LA; Erwenne CM
Arq Bras Oftalmol; 2005; 68(3):327-31. PubMed ID: 16059563
[TBL] [Abstract][Full Text] [Related]
17. Vitrectomy in eyes with unsuspected retinoblastoma.
Shields CL; Honavar S; Shields JA; Demirci H; Meadows AT
Ophthalmology; 2000 Dec; 107(12):2250-5. PubMed ID: 11097606
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
[TBL] [Abstract][Full Text] [Related]
19. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
[TBL] [Abstract][Full Text] [Related]
20. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
